| Name | Title | Contact Details |
|---|---|---|
Philip Yachmetz |
Chief Legal Officer and Corporate Secretary | Profile |
Martin Wilson |
General Counsel | Profile |
Martin Wilson |
General Counsel | Profile |
We design affordable, safe and effective drugs to safeguard and empower the brain throughout all stages of life. Our aim is to improve quality of life and longevity.
Redox Pharmaceutical Corp. is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ophthotech is a biopharmaceutical company specializing in the development of novel therapeutics to treat back of the eye diseases, with a focus on developing innovative therapies for age-related macular degeneration (AMD). Ophthotech`s most advanced product candidate, Fovista® anti-PDGF therapy, is in Phase 3 clinical trials for use in combination with anti-VEGF therapy that represents the current standard of care for the treatment of wet AMD. Ophthotech`s second product candidate, Zimura®, an inhibitor of complement factor C5, is being developed for the treatment of geographic atrophy, a form of dry AMD.
Insertec is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hospice Provider Group Inc is a Sarasota, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.